We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
-$110M
Cap. Flow
-$166M
Cap. Flow %
-8.36%
Top 10 Hldgs %
54.66%
Holding
88
New
23
Increased
17
Reduced
12
Closed
35

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$115M
2
HCA icon
HCA Healthcare
HCA
+$108M
3
CVRS
CORINDUS VASCULAR ROBOTICS, INC
CVRS
+$85.2M
4
AKRX
Akorn Inc
AKRX
+$79.8M
5
RAD
Rite Aid Corporation
RAD
+$56.5M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$68M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$67M
3
BIIB icon
Biogen
BIIB
+$63.6M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$56.2M
5
BSX icon
Boston Scientific
BSX
+$42.4M

Sector Composition

Rank Sector Weight
1 Healthcare 60.27%
2 Financials 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PDCO
76
DELISTED
Patterson Companies, Inc.
PDCO
– –
-570,000
Closed -$27.8M
ARAV
77
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-152,933
Closed -$16.9M
ISEE
78
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-34,300
Closed -$1.6M
AERI
79
DELISTED
Aerie Pharmaceuticals
AERI
– –
-350,000
Closed -$11M
TTPH
80
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-23,360
Closed -$17.1M
ELGX
81
DELISTED
Endologix Inc
ELGX
– –
-57,580
Closed -$9.83M
TSRO
82
PUT
DELISTED
TESARO, Inc.
TSRO
– –
-500,000
Closed -$28.7M
WBMD
83
DELISTED
WebMD Health Corp.
WBMD
– –
-855,555
Closed -$37.5M
AMRI
84
DELISTED
Albany Molecular Research Inc
AMRI
– –
-1,275,000
Closed -$22.4M
DYAX
85
DELISTED
DYAX CORPORATION
DYAX
– –
-489,900
Closed -$8.21M
KYTH
86
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
– –
-425,000
Closed -$21.3M
DSCI
87
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
– –
-893,600
Closed -$7.57M
LENS
88
DELISTED
Presbia PLC Ordinary Shares
LENS
– –
-56,869
Closed -$420K
1 2 3
4

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q2 2015 Portfolio in Review

As of Q2 2015, HealthCor Management held 88 positions worth $1.99B, down 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

HealthCor Management withdrew a net $166M in Q2 2015, closing 35 positions and reducing 12 holdings. Its most notable exit was Viatris, an estimated $68M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 61% a quarter earlier, followed by Financials.

Against the trend, HealthCor Management opened a new position in HCA Healthcare worth $122M.

  • HealthCor Management's largest Q2 2015 buy was HCA Healthcare: 1,350,000 shares worth $122M.
  • HealthCor Management added most to Edwards Lifesciences in Q2 2015, an estimated $115M increase.
  • HealthCor Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $67M.
  • HealthCor Management fully exited Viatris in Q2 2015, selling an estimated $68M.
  • HealthCor Management's ten largest holdings make up 55% of its $1.99B portfolio in Q2 2015.
  • HealthCor Management opened 23 new positions and closed 35 in Q2 2015.
  • HealthCor Management's portfolio value fell 5.2% quarter-over-quarter to $1.99B.

Based on HealthCor Management's 13F filing for Q2 2015, filed 14 Aug 2015.